InvestorsHub Logo
Followers 66
Posts 1920
Boards Moderated 1
Alias Born 06/14/2001

Re: None

Tuesday, 07/14/2009 9:56:14 AM

Tuesday, July 14, 2009 9:56:14 AM

Post# of 376163
HITK - Huge play IMH - reported 0.45 for the Q, way above the analyst estimate of 0.20 - 13 products in FDA approval, 20 products under development, sector PE average 30 and they may be floating around 4-7 forward PE with no debt. At current earnings rate, this has all the rights to be valued $50 or higher.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.